Phase II trial of AMG 221 in patients with type 2 diabetes mellitus.

Trial Profile

Phase II trial of AMG 221 in patients with type 2 diabetes mellitus.

Not stated
Phase of Trial: Phase II

Latest Information Update: 29 Apr 2011

At a glance

  • Drugs AMG 221 (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Amgen
  • Most Recent Events

    • 29 Apr 2011 Status changed from planning to unconfirmed (trial never initiated and development of AMG 221 has been discontinued).
    • 21 Jan 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top